Full-Year Revenue -- $6.3 million, a 9% increase, driven by 4% growth in product sales and a 27% increase in engineering ...
Vuzix Corporation (NASDAQ:VUZI) Q4 2025 Earnings Call Transcript March 12, 2026 Vuzix Corporation misses on earnings expectations. Reported EPS is $-0.12 EPS, expectations were $-0.09. Operator: ...
Background Metabolic-associated steatotic liver disease (MASLD) is a prevalent chronic liver disease affecting approximately a third of the global population. Early identification is critical for ...
Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsEdward McGregor - Director of Investor RelationsPaul Travers ...
Scientists have developed Evo 2, a powerful AI model that can analyze and generate DNA sequences across all domains of life.
Explore how DFMEA transforms product development by identifying potential risks, optimizing designs, and ensuring compliance with regulatory standards.
Evidence is provided suggesting that aggregate neural activity at an early stage of visual processing (V1) can directly contribute to perceptual decisions in humans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results